Animal Drugs, Feeds, and Related Products; Withdrawal of Approval of New Animal Drug Applications, 74652-74653 [05-24104]

Download as PDF 74652 Federal Register / Vol. 70, No. 241 / Friday, December 16, 2005 / Rules and Regulations introductory text, and the first sentence of paragraph (e)(i), remove ‘‘duplicate or corrected’’ and add in its place ‘‘replacement.’’ I b. In the third and fourth sentences of paragraph (a), the first sentence of paragraph (d) introductory text, and the first sentence of paragraph (g), remove ‘‘,duplicate, or corrected’’ and add in its place ‘‘or replacement.’’ I 4. Section 422.110 is revised to read as follows: § 422.110 Individual’s request for change in record. (a) Form SS–5. If you wish to change the name or other personal identifying information you previously submitted in connection with an application for a social security number card, you must complete and sign a Form SS–5 except as provided in paragraph (b) of this section. You must prove your identity, and you may be required to provide other evidence. (See § 422.107 for evidence requirements.) You may obtain a Form SS–5 from any local Social Security office or from one of the sources noted in § 422.103(b). You may submit a completed request for change in records to any Social Security office, or, if you are outside the U.S., to the Department of Veterans Affairs Regional Office, Manila, Philippines, or to any U.S. Foreign Service post or U.S. military post. If your request is for a change of name on the card, we may issue you a replacement card bearing the same number and the new name. We will grant an exception from the limitations specified in § 422.103(e)(2) for replacement social security number cards representing a change in name or, if you are an alien, a change to a restrictive legend shown on the card. (See § 422.103(e)(3) for the definition of a change to a restrictive legend.) (b) Assisting in enumeration. We may enter into an agreement with officials of the Department of State and the Department of Homeland Security to assist us by collecting, as part of the immigration process, information to change the name or other personal identifying information you previously submitted in connection with an application or request for a social security number card. If your request is to change a name on the card or to correct the restrictive legend on the card to reflect a change in alien status, we may issue you a replacement card bearing the same number and the new name or legend. We will grant an exception from the limitations specified in § 422.103(e)(2) for replacement social security number cards representing a change of name or, if you are an alien, a change to a restrictive legend shown on the card. (See § 422.103(e)(3) for the definition of a change to a restrictive legend.) [FR Doc. 05–23962 Filed 12–15–05; 8:45 am] BILLING CODE 4191–02–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration 21 CFR Parts 510 and 558 Animal Drugs, Feeds, and Related Products; Withdrawal of Approval of New Animal Drug Applications AGENCY: Food and Drug Administration, HHS. ACTION: Final rule. SUMMARY: The Food and Drug Administration (FDA) is amending the animal drug regulations by removing those portions that reflect approval of 15 new animal drug applications (NADAs) because the products are no longer manufactured or marketed. In a notice published elsewhere in this issue of the Federal Register, FDA is withdrawing approval of the NADAs. DATES: This rule is effective December 27, 2005. FOR FURTHER INFORMATION CONTACT: Pamela K. Esposito, Center for Veterinary Medicine (HFV–212), Food and Drug Administration, 7519 Standish Pl., Rockville, MD 20855, 240–276– 9067, e-mail: pesposit@cvm.fda.gov. SUPPLEMENTARY INFORMATION: The following sponsors have requested that FDA withdraw approval of the 15 NADAs listed in table 1 of this document because the products are no longer manufactured or marketed: TABLE 1. Sponsor 21 CFR Section Affected (Sponsor Drug Labeler Code) NADA Number, Product (Drug) Bioproducts, Inc., 320 Springside Dr., Suite 300, Fairlawn, OH 44333–2435 NADA 119–063, Pyrantel Tartrate Ton Pack (pyrantel tartrate) 558.485 (051359) Farmland Industries, Inc., Kansas City, MO 64116 NADA 138–656, BN Wormer—19.2 BANMINTH Premix (pyrantel tartrate) 558.485 (021676) I.M.S. Inc., 13619 Industrial Rd., Omaha, NE 68137 NADA 129–395, HYGROMIX 0.6 Premix (hygromycin B) 558.274 (050639) NADA 129–646, TYLAN 10 Sulfa-G (tylosin, sulfamethazine) NADA 136–601, Swine Guard BN (pyrantel tartrate) 558.630 (050639) 558.485 (050639) J. & R. Specialty Supply Co., 310 Second Ave., SW., P.O. Box 506, Waseca, MN 56093 NADA 96–780, TYLAN 10; TYLAN 40 (tylosin) n/a (049768) Kerber Milling Co., Box 152, 1817 E. Main St., Emmetsburg, IA 50536 NADA 98–687, Hy-Test Hy-Boost TY 5 Medicated (tylosin) 558.625 (029341) M & M Livestock Products Co., Eagle Grove, IA 50533 NADA 96–837, M & M Tylosin Premix (tylosin) 558.625 (026282) Nutra-Blend Corp., P.O. Box 485, Neosho, MO 64850 NADA 129–161, Nutra-Blend TYLAN 10 Sulfa Premix (tylosin, sulfamethazine) NADA 136–384, Swine Wormer-BN BANMINTH (pyrantel tartrate) 558.630 (050568) VerDate Aug<31>2005 16:21 Dec 15, 2005 Jkt 208001 PO 00000 Frm 00014 Fmt 4700 Sfmt 4700 E:\FR\FM\16DER1.SGM 16DER1 558.485 (050568) Federal Register / Vol. 70, No. 241 / Friday, December 16, 2005 / Rules and Regulations 74653 TABLE 1.—Continued Sponsor 21 CFR Section Affected (Sponsor Drug Labeler Code) NADA Number, Product (Drug) South St. Paul Feeds, Inc., 500 Farwell Ave., South St. Paul, MN 55075 NADA 136–369, Custom Ban Wormer 9.6 (pyrantel tartrate) 558.485 (001800) Stockton Hay & Grain Co. NADA 49–462, Rainbrook Broiler Premix No. 1 (ampolium, arsanilic acid, ethopabate, penicillin G procaine, streptomycin) NADA 91–646, Rainbow Broiler Base Concentrate (ampolium, bacitracin zinc, ethopabate) NADA 91–647, Rainbow Broiler Base Concentrate (ampolium, chlortetracycline, ethopabate) n/a (036541) n/a (036541) NADA 131–146, FLAVOMYCIN 0.4 (bambermycins) 558.95 (011490) Triple ‘‘F’’, Inc., 10104 Douglas Ave., Des Moines, IA 50322 Following the withdrawal of approval of these NADAs, Kerber Milling Co., M & M Livestock Products Co., NutraBlend Corp., and South St. Paul Feeds, Inc., are no longer sponsors of an approved application. Therefore, we are removing entries for these four sponsors from 21 CFR 510.600(c). As provided below, the animal drug regulations are amended to reflect the withdrawal of approvals. This rule does not meet the definition of ‘‘rule’’ in 5 U.S.C. 804(3)(A) because it is a rule of ‘‘particular applicability.’’ Therefore, it is not subject to the congressional review requirements in 5 U.S.C. 801–808. paragraph (c)(2) by removing the entries for ‘‘001800’’, ‘‘026282’’, ‘‘029341’’, and ‘‘050568’’. DEPARTMENT OF JUSTICE PART 558—NEW ANIMAL DRUGS FOR USE IN ANIMAL FEEDS 21 CFR Parts 1300 and 1308 Authority: 21 U.S.C. 360b, 371. § 558.95 [Amended] 4. Section 558.95 is amended by removing and reserving paragraph (a)(3). I § 558.274 [Amended] Administrative practice and procedure, Animal drugs, Labeling, Reporting and recordkeeping requirements. 21 CFR Part 558 § 558.485 Animal drugs, Animal feeds. Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, 21 CFR parts 510 and 558 are amended as follows: I PART 510—NEW ANIMAL DRUGS I I 1. The authority citation for 21 CFR part 510 continues to read as follows: § 558.630 Authority: 21 U.S.C. 321, 331, 351, 352, 353, 360b, 371, 379e. 2. Section 510.600 is amended in the table in paragraph (c)(1) by removing the entries for ‘‘Kerber Milling Co.’’, ‘‘M & M Livestock Products Co.’’, ‘‘NutraBlend Corp.’’, and ‘‘South St. Paul Feeds, Inc.’’; and in the table in VerDate Aug<31>2005 16:21 Dec 15, 2005 Jkt 208001 [Amended] 8. Section 558.630 is amended in paragraph (b)(10) by removing ‘‘, 050568, 050639’’. I [Amended] I [Amended] 7. Section 558.625 is amended by removing and reserving paragraphs (b)(22), (b)(31), (b)(52), and (b)(79). I § 510.600 [Amended] 6. Section 558.485 is amended by removing and reserving paragraphs (b)(2) and (b)(4); and in paragraph (b)(3) by removing ‘‘, 049685, 050568, 050639, and 051359’’ and by adding in its place ‘‘and 049685’’. § 558.625 Dated: December 7, 2005. Stephen F. Sundlof, Director, Center for Veterinary Medicine. [FR Doc. 05–24104 Filed 12–15–05; 8:45 am] BILLING CODE 4160–01–S PO 00000 Frm 00015 Fmt 4700 Sfmt 4700 RIN 1117–AA95 Implementation of the Anabolic Steroid Control Act of 2004 5. Section 558.274 is amended in paragraph (a)(4) by removing ‘‘, 043733, and 050639’’ and by adding in its place ‘‘and 043733’’; and in the table in paragraphs (c)(1)(i) and (c)(1)(ii) in the ‘‘Sponsor’’ column by removing ‘‘, 050639’’. 21 CFR Part 510 Drug Enforcement Administration [Docket No. DEA–264] 3. The authority citation for 21 CFR part 558 continues to read as follows: I I List of Subjects n/a (036541) Drug Enforcement Administration (DEA), Department of Justice. ACTION: Final rule. AGENCY: SUMMARY: The purpose of this rulemaking is to conform the Drug Enforcement Administration’s (DEA) regulations to the provisions of the Anabolic Steroid Control Act of 2004. Effective January 20, 2005, the Act amended the Controlled Substances Act (CSA) and replaced the existing definition of ‘‘anabolic steroid’’ with a new definition. This new definition altered the basis for all future administrative scheduling actions relating to the control of anabolic steroids as Schedule III controlled substances by eliminating the requirement to prove muscle growth. Additionally, the Act lists 59 specific substances as being anabolic steroids. As such, these substances and their salts, esters and ethers are Schedule III controlled substances. This rulemaking amends 21 CFR Parts 1300 and 1308 to reflect these changes. The Act also amends the CSA by revising the language requiring exclusion of certain over the counter products from regulation as controlled substances. The Act clarifies that the exclusionary language in 21 U.S.C. 811(g)(1) pertains only to non-narcotic ‘‘drugs’’ that may, under the Federal Food, Drug, and Cosmetic Act (FDCA), E:\FR\FM\16DER1.SGM 16DER1

Agencies

[Federal Register Volume 70, Number 241 (Friday, December 16, 2005)]
[Rules and Regulations]
[Pages 74652-74653]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-24104]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

21 CFR Parts 510 and 558


Animal Drugs, Feeds, and Related Products; Withdrawal of Approval 
of New Animal Drug Applications

AGENCY: Food and Drug Administration, HHS.

ACTION: Final rule.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is amending the animal 
drug regulations by removing those portions that reflect approval of 15 
new animal drug applications (NADAs) because the products are no longer 
manufactured or marketed. In a notice published elsewhere in this issue 
of the Federal Register, FDA is withdrawing approval of the NADAs.

DATES: This rule is effective December 27, 2005.

FOR FURTHER INFORMATION CONTACT: Pamela K. Esposito, Center for 
Veterinary Medicine (HFV-212), Food and Drug Administration, 7519 
Standish Pl., Rockville, MD 20855, 240-276-9067, e-mail: 
pesposit@cvm.fda.gov.

SUPPLEMENTARY INFORMATION: The following sponsors have requested that 
FDA withdraw approval of the 15 NADAs listed in table 1 of this 
document because the products are no longer manufactured or marketed:

                                                    Table 1.
----------------------------------------------------------------------------------------------------------------
                                                                                                 21 CFR Section
                                                                                               Affected (Sponsor
               Sponsor                               NADA Number, Product (Drug)                  Drug Labeler
                                                                                                     Code)
----------------------------------------------------------------------------------------------------------------
Bioproducts, Inc., 320 Springside      NADA 119-063, Pyrantel Tartrate Ton Pack (pyrantel      558.485 (051359)
 Dr., Suite 300, Fairlawn, OH 44333-    tartrate)
 2435
----------------------------------------------------------------------------------------------------------------
Farmland Industries, Inc., Kansas      NADA 138-656, BN Wormer--19.2 BANMINTH Premix           558.485 (021676)
 City, MO 64116                         (pyrantel tartrate)
----------------------------------------------------------------------------------------------------------------
I.M.S. Inc., 13619 Industrial Rd.,     NADA 129-395, HYGROMIX 0.6 Premix (hygromycin B)        558.274 (050639)
 Omaha, NE 68137
                                       NADA 129-646, TYLAN 10 Sulfa-G (tylosin,                558.630 (050639)
                                        sulfamethazine)
                                       NADA 136-601, Swine Guard BN (pyrantel tartrate)        558.485 (050639)
----------------------------------------------------------------------------------------------------------------
J. & R. Specialty Supply Co., 310      NADA 96-780, TYLAN 10; TYLAN 40 (tylosin)               n/a (049768)
 Second Ave., SW., P.O. Box 506,
 Waseca, MN 56093
----------------------------------------------------------------------------------------------------------------
Kerber Milling Co., Box 152, 1817 E.   NADA 98-687, Hy-Test Hy-Boost TY 5 Medicated (tylosin)  558.625 (029341)
 Main St., Emmetsburg, IA 50536
----------------------------------------------------------------------------------------------------------------
M & M Livestock Products Co., Eagle    NADA 96-837, M & M Tylosin Premix (tylosin)             558.625 (026282)
 Grove, IA 50533
----------------------------------------------------------------------------------------------------------------
Nutra-Blend Corp., P.O. Box 485,       NADA 129-161, Nutra-Blend TYLAN 10 Sulfa Premix         558.630 (050568)
 Neosho, MO 64850                       (tylosin, sulfamethazine)
                                       NADA 136-384, Swine Wormer-BN BANMINTH (pyrantel        558.485 (050568)
                                        tartrate)
----------------------------------------------------------------------------------------------------------------

[[Page 74653]]

 
South St. Paul Feeds, Inc., 500        NADA 136-369, Custom Ban Wormer 9.6 (pyrantel           558.485 (001800)
 Farwell Ave., South St. Paul, MN       tartrate)
 55075
----------------------------------------------------------------------------------------------------------------
Stockton Hay & Grain Co.               NADA 49-462, Rainbrook Broiler Premix No. 1 (ampolium,  n/a (036541)
                                        arsanilic acid, ethopabate, penicillin G procaine,
                                        streptomycin)
                                       NADA 91-646, Rainbow Broiler Base Concentrate           n/a (036541)
                                        (ampolium, bacitracin zinc, ethopabate)
                                       NADA 91-647, Rainbow Broiler Base Concentrate           n/a (036541)
                                        (ampolium, chlortetracycline, ethopabate)
----------------------------------------------------------------------------------------------------------------
Triple ``F'', Inc., 10104 Douglas      NADA 131-146, FLAVOMYCIN 0.4 (bambermycins)             558.95 (011490)
 Ave., Des Moines, IA 50322
----------------------------------------------------------------------------------------------------------------

    Following the withdrawal of approval of these NADAs, Kerber Milling 
Co., M & M Livestock Products Co., Nutra-Blend Corp., and South St. 
Paul Feeds, Inc., are no longer sponsors of an approved application. 
Therefore, we are removing entries for these four sponsors from 21 CFR 
510.600(c).
    As provided below, the animal drug regulations are amended to 
reflect the withdrawal of approvals.
    This rule does not meet the definition of ``rule'' in 5 U.S.C. 
804(3)(A) because it is a rule of ``particular applicability.'' 
Therefore, it is not subject to the congressional review requirements 
in 5 U.S.C. 801-808.

List of Subjects

21 CFR Part 510

    Administrative practice and procedure, Animal drugs, Labeling, 
Reporting and recordkeeping requirements.

21 CFR Part 558

    Animal drugs, Animal feeds.

0
Therefore, under the Federal Food, Drug, and Cosmetic Act and under 
authority delegated to the Commissioner of Food and Drugs and 
redelegated to the Center for Veterinary Medicine, 21 CFR parts 510 and 
558 are amended as follows:

PART 510--NEW ANIMAL DRUGS

0
1. The authority citation for 21 CFR part 510 continues to read as 
follows:

    Authority: 21 U.S.C. 321, 331, 351, 352, 353, 360b, 371, 379e.


Sec.  510.600  [Amended]

0
2. Section 510.600 is amended in the table in paragraph (c)(1) by 
removing the entries for ``Kerber Milling Co.'', ``M & M Livestock 
Products Co.'', ``Nutra-Blend Corp.'', and ``South St. Paul Feeds, 
Inc.''; and in the table in paragraph (c)(2) by removing the entries 
for ``001800'', ``026282'', ``029341'', and ``050568''.

PART 558--NEW ANIMAL DRUGS FOR USE IN ANIMAL FEEDS

0
3. The authority citation for 21 CFR part 558 continues to read as 
follows:

    Authority: 21 U.S.C. 360b, 371.


Sec.  558.95  [Amended]

0
4. Section 558.95 is amended by removing and reserving paragraph 
(a)(3).


Sec.  558.274  [Amended]

0
5. Section 558.274 is amended in paragraph (a)(4) by removing ``, 
043733, and 050639'' and by adding in its place ``and 043733''; and in 
the table in paragraphs (c)(1)(i) and (c)(1)(ii) in the ``Sponsor'' 
column by removing ``, 050639''.


Sec.  558.485  [Amended]

0
6. Section 558.485 is amended by removing and reserving paragraphs 
(b)(2) and (b)(4); and in paragraph (b)(3) by removing ``, 049685, 
050568, 050639, and 051359'' and by adding in its place ``and 049685''.


Sec.  558.625  [Amended]

0
7. Section 558.625 is amended by removing and reserving paragraphs 
(b)(22), (b)(31), (b)(52), and (b)(79).


Sec.  558.630  [Amended]

0
8. Section 558.630 is amended in paragraph (b)(10) by removing ``, 
050568, 050639''.

    Dated: December 7, 2005.
Stephen F. Sundlof,
Director, Center for Veterinary Medicine.
[FR Doc. 05-24104 Filed 12-15-05; 8:45 am]
BILLING CODE 4160-01-S
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.